2.050
+0.110
+(5.67%)
At close: 4:08:06 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
491,373
491,373
406,461
415,862
276,047
Cost of Revenue
102,168
102,168
92,463
91,518
48,767
Gross Profit
389,205
389,205
313,998
324,344
227,280
Operating Expense
960,284
960,284
948,883
596,301
376,138
Operating Income
-571,079
-571,079
-634,885
-271,957
-148,858
Net Non Operating Interest Income Expense
-28,259
-28,259
-9,975
47,575
30,495
Pretax Income
-735,340
-735,340
-1,156,344
-377,555
-185,843
Tax Provision
-6,284
-6,284
-34,302
-6,161
-2,975
Net Income Common Stockholders
-703,754
-703,754
-1,057,699
-373,636
-181,989
Diluted NI Available to Com Stockholders
-703,754
-703,754
-1,057,699
-373,636
-181,989
Basic EPS
-1.61
-1.65
-2.42
-0.85
-0.45
Diluted EPS
-1.61
-1.65
-2.42
-0.85
-0.45
Basic Average Shares
437,897.443
437,897.443
437,897.443
438,577.016
409,265.072
Diluted Average Shares
437,897.443
437,897.443
437,897.443
438,577.016
409,265.072
Total Expenses
1,062,452
1,062,452
1,041,346
687,819
424,905
Net Income from Continuing & Discontinued Operation
-703,754
-703,754
-1,057,699
-373,636
-181,989
Normalized Income
-886,264.872
-886,264.872
-1,036,378.781
-615,500.742
-234,692.588
Interest Income
34,457
34,457
34,648
49,480
34,667
Interest Expense
62,716
62,716
44,623
1,905
2,159
Net Interest Income
-28,259
-28,259
-9,975
47,575
30,495
EBIT
-672,624
-672,624
-1,111,721
-375,650
-183,684
EBITDA
-547,837
-547,837
-999,369
-324,029
-145,972
Reconciled Cost of Revenue
102,168
102,168
92,463
91,518
48,767
Reconciled Depreciation
124,787
124,787
112,352
51,621
37,712
Net Income from Continuing Operation Net Minority Interest
-703,754
-703,754
-1,057,699
-373,636
-181,989
Total Unusual Items Excluding Goodwill
184,084
184,084
-21,972
245,877
53,561
Total Unusual Items
184,084
184,084
-21,972
245,877
53,561
Normalized EBITDA
-731,921
-731,921
-977,397
-569,906
-199,533
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,573.128
1,573.128
-651.781
4,012.258
857.412
12/31/2020 - 12/10/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6922.HK Cryofocus Medtech (Shanghai) Co., Ltd.
3.680
-1.34%
1302.HK LIFETECH SCI
1.360
+1.49%
0853.HK MICROPORT
6.600
-1.05%
688016.SS Shanghai MicroPort Endovascular MedTech Co., Ltd.
87.46
+0.32%
9877.HK Jenscare Scientific Co., Ltd.
3.740
-5.79%
9996.HK Peijia Medical Limited
4.370
-1.13%
1696.HK SISRAM MED
4.310
+2.62%
HAE Haemonetics Corporation
57.51
+2.62%
2252.HK Shanghai MicroPort MedBot (Group) Co., Ltd.
15.680
+7.54%
XTNT Xtant Medical Holdings, Inc.
0.3701
-2.94%